Skip to content

Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery

Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05907915
Enrollment
40
Registered
2023-06-18
Start date
2022-11-01
Completion date
2023-04-30
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Graft

Brief summary

PURPOSE: The purpose of the study is to evaluate the effect of (LLLT) on donor site wound healing following skin graft surgery. BACKGROUND: The skin graft is a beneficial reconstructive technique for accelerating wound healing .Managing donor site after graft harvesting is very important, and often, patients have more discomfort at the donor site than the recipient burn site itself.Using techniques that accelerate wound healing may enhance patient satisfaction. Low-level laser therapy (LLLT) has been used in several medical fields, including healing of diabetic, surgical, and pressure ulcers. Accelerating the healing process and reducing pain during healing are beneficial for the following reasons: faster return to work, lower risk of wound infection, improved quality of life, and possibly reduced need for analgesia. HYPOTHESES: It is hypothesized that: Low level laser therapy has a positive effect on donor site wound healing following skin graft surgery in burned patients. RESEARCH QUESTION: Is low level laser therapy has a positive effect on donor site healing following skin graft surgery in burned patients?

Interventions

DEVICElow level laser therapy

They recieved LLLT 1 session daily, 3 session per week for 3 weeks,with the following parameters( 650 nm wavelength, 150 mw power output, 0.25 cm2 radiation area, 0.6 W/cm2 power density, continuous mode, 2 j/ cm2, 90 seconds / cm2) in addition to the conventional medical treatment and traditional wound care (dressing)

BEHAVIORALplacebo

They received placebo laser 1 session daily, 3 session per week for 3 weeks in addition to the conventional medical treatment and traditional wound care (dressing)

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients are both males and females. * Their Age will be range between 20-40 years. * All patients suffering from third degree burn with TBSA for burn will be ranged from 20% to 35%. * All patients undergoing split thickness skin graft surgery. * All patients will begin the treatment program from the 1st day post operative * All patients enrolled to the study will have their informed consent. * All patients have donor sites from the thigh.

Exclusion criteria

* • Patients with associated diseases (Diabetes mellitus, infectious diseases, autoimmune disease) that will interfere with the healing process. * Patients taking medication that alter the healing process (e.g., corticosteroids, chemotherapy or radiation. * Pregnancy or epilepsy. * Elderly patients. * Subjects who have photosensitive problems * History of trauma or accidental injuries. * Skin diseases. * History of surgery on particular donor site.

Design outcomes

Primary

MeasureTime frameDescription
Measurement of wound surface area at day 1 post-operative (pre-treatment)(baseline measurement)1 dayMeasurement of wound surface area by photography and image J software at day 1
Measurement of wound surface area at day 11 post-operative (post-treatment)11 dayMeasurement of wound surface area by photography and image J software at day 11
Measurement of wound surface area at day 21 post-operative (post-treatment)21 dayMeasurement of wound surface area by photography and image J software at day 21

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026